↗3 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$156KSold on the market
1Companies
Oct 22, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 22, 202616:10 | Oct 20, 2026 | DYNDyne Therapeutics, Inc. | Head of R&D and CMO | A · Grant | — | +8,000 | 170,564 | +5% | — | ||
| Sep 8, 202616:14 | Sep 8, 2026from Sep 4, 2026 | DYNDyne Therapeutics, Inc. | Chief Medical Officer | S · Sell10b5-1 | $22.95 | −5,035 | 162,564 | -3% | −$116K | ||
| Aug 17, 202616:08 | Aug 13, 2026 | DYNDyne Therapeutics, Inc. | Chief Medical Officer | S · Sell10b5-1 | $26.28 | −1,556 | 167,599 | -1% | −$41K |